Article Sidebar
Main Article Content
Abstract
Pulmonary tuberculosis (TB) is an infectious disease that attacks the lungs and is caused by the bacterium Mycobacterium tuberculosis. The GeneXpert RT-PCR examination (Xpert MTB / RIF) is a development of a diagnostic tool that can automatically detect the presence of Mycobacterium tuberculosis (MTB) by molecular examination and can be used to detect MTB resistance to rifampicin. Erythrocyte sedimentation rate (ESR) is a test used to determine the rate at which erythrocytes settle in the blood. The purpose of this study was to determine the relationship between GeneXpert RT-PCR results and ESR in suspected tuberculosis patients. This research uses a cross-sectional study. The sample used in this study were 56 new suspected TB patients who had never been treated for ATD and underwent GeneXpert RT-PCR examination. Sampling was carried out by purposive sampling with the TCM Rif Sen group and negative results. A total of 27 patients (96.4%) with Rif Sen's GeneXpert RT-PCR results had high ESR values. 15 patients (53.6%) with negative GeneXpert RT-PCR results had normal ESR values. The results of the Chi Square test (X2) show that p-value = 0.000 OR = 0.032. There is a significant relationship between GeneXpert and ESR values in suspected tuberculosis
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Alamlih, L. et al. (2020) ‘Hematologic Characteristics of Patients with Active Pulmonary, Extra-Pulmonary and Disseminated Tuberculosis: A Study of over Six Hundred Patients’, Journal of Tuberculosis Research, 08(02), pp. 33–41. doi: 10.4236/jtr.2020.82004.
Boehme, C. C. et al. (2011) 'Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study', The Lancet, 377(9776), pp. 1495–1505. doi: 10.1016/S0140-6736(11)60438-8.
Costantini, L., Marando, M. and Gianella, P. (2020) ‘Long-Term GeneXpert Positivity after Treatment for Pulmonary Tuberculosis’, European Journal of Case Reports in Internal Medicine, 2021(8), p. 12890. doi: 10.12890/2020.
Dewi, A. A. I. S., Andrika, P. and Artana, I. B. (2020) ‘Gambaran Karateristik Pasien Tuberculosis Di Poliklinik Paru Rsup Sanglah Denpasar’, Jurnal Medika Udayana, Vol. 9 No.6, 9(1), pp. 22–27. Available at: https://ojs.unud.ac.id/index.php/eum/article/view/60533/35024.
Dina, D., Zaini, M. and Yahya, Y. (2019) ‘Gambaran Pemeriksaaan Hapusan Darah Tepi Diffcount (Sel Limfosit) Pada Penderita TBC Di Puskesmas Kelayan Timur Banjarmasin’, Jurnal Kajian Ilmiah Kesehatan dan …, 1(2), pp. 34–38. Available at: http://jurnal.polanka.ac.id/index.php/JKIKT/article/view/8.
DinkesProv Jateng (2021) Profil Kesehatan Jawa Tengah Tahun 2021. Semarang.
Elbrolosy, A. M. et al. (2021) ‘Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis’, BMC Microbiology, 21(1), pp. 1–10. doi: 10.1186/s12866-021-02210-5.
Hasnawati (2018) ‘Pengaruh Infeksi Mycobacterium tuberculosis Terhadap Nilai Laju Endap Darah Penderita Tuberculosis Paru di Balai Besar Kesehatan Paru Masyarakat’, Jurnal Media Analis Kesehatan, 1(1), pp. 8–13. doi: 10.32382/mak.v1i1.119.
Hidriyah, S., Rahmita, M. and Trisna, C. (2018) ‘Perbandingan Nilai Laju Endap Darah (Led) Antara Metode Westergren Dengan Metode Mikro Esr Pada Penderita Tuberkulosis
Paru’, Jurnal Medikes (Media Informasi Kesehatan), 5(2), pp. 182–191. doi: 10.36743/medikes.v5i2.59.
Kasih, K. N. and Sulastina, N. A. (2019) ‘Analisis Laju Endap Darah Pada Pasien Tuberkulosis Paru’, Jurnal ’Aisyiyah Medika, 4(1), pp. 44–52. doi: 10.36729/jam.v4i1.232.
Kemenkes (2022) Jumlah Kasus TB Tahun 2000-2022, Kementerian Kesehatan. Available at: https://tbindonesia.or.id/pustaka-tbc/dashboard-tb/.
Kouassi, K. N. guessa. et al. (2016) ‘Genotyping of mutations detected with GeneXpert’, International Journal of Mycobacteriology, 5(2), pp. 142–147. doi: 10.1016/j.ijmyco.2016.01.001.
Laily, D. W., Rombot, D. V and Lampus, B. S. (2015) ‘Karakteristik Pasien Tuberkulosis Paru Di Puskesmas Tuminting Manado’, Jurnal Kedokteran dan Tropik, 3(1), pp. 1–5.
Naim, N. (2019) ‘Result Analysis of Erythrocyte Sedimentation Rate (ESR) For Tuberculosis (TB) Patient with Anti-Tuberculosis Drug’, International Journal of Science and Healthcare Research (www.ijshr.com), 4(2), pp. 143–148. Available at: www.ijshr.com.
Naim, N. and Dewi, N. U. (2018) ‘Performa Tes Cepat Molekuler Dalam Diagnosa Tuberkulosis Di Balai Besar Kesehatan Paru Masyarakat Makassar’, Jurnal Media Analis Kesehatan, 9(2), pp. 113–122. doi: 10.32382/mak.v9i2.678.
Nugraha, G. and Badrawi, I. (2018) Pedoman Teknik Pemeriksaan Laboratorium Klinik, Trans Info Media. Available at: www.transinfotim.blogspot.com.
Permatasari, S. et al. (2021) ‘Validitas Metode Real Time PCR GeneXpert pada Suspek TB Paru BTA Negatif di RSUD Dr. Doris Sylvanus’, Jurnal Surya Medika, 7(1), pp. 88–93. doi: 10.33084/jsm.v7i1.2037.
Qo’imah, A. N. et al. (2022) ‘Comparison of TSH Levels Pulmonary Tuberculosis Patients at The Phase 0 and 6 Months Treatment’, Jurnal Ilmu dan Teknologi Kesehatan, 10(1), pp. 99–107. doi: 10.32668/jitek.v10i1.910.
Restrepo, B. I. (2018) ‘Diabetes and tuberculosis’, Understanding the Host Immune Response Against Mycobacterium tuberculosis Infection, (9), pp. 1–21. doi: 10.1007/978-3-319-97367-8_1.
Rizqiya, R. N., Wuryaningsih, E. W. and Deviantony, F. (2021) ‘Hubungan Stigma Masyarakat Dengan Kepatuhan Minum Obat Pasien Tb Paru Di Puskesmas Puhjarak Kecamatan Plemahan Kabupaten Kediri’, Jurnal Ilmiah Kesehatan Keperawatan, 17(1), p. 66. doi: 10.26753/jikk.v17i1.511.
Sasikumar, C. et al. (2020) ‘The role of genexpert in the diagnosis of mycobacterium tuberculosis’, Advances in Respiratory Medicine, 88(3), pp. 184–188. doi: 10.5603/ARM.2020.0102.
Solanki, A. M. et al. (2020) ‘Sensitivity and Specificity of Gene Xpert in the Diagnosis of Spinal Tuberculosis: A Prospective Controlled Clinical Study’, Global Spine Journal, 10(5), pp. 553–558. doi: 10.1177/2192568219858310.
Sorsa, A. (2020) ‘The diagnostic performance of chest-x-ray and erythrocyte sedimentation rate in comparison with genexpert® for tuberculosis case notification among patients living with human immunodeficiency virus in a resource-limited setting: A cross-sectional study’, Risk Management and Healthcare Policy, 13, pp. 1639–1646. doi:
2147/RMHP.S264447.
Sulochana, S. et al. (2022) ‘Clinical Significance of Erythrocyte Sedimentation Rate in Tuberculosis’, Research Journal of Pharmacy and Technology, 15(1), pp. 245–249. doi: 10.52711/0974-360X.2022.00040.
Utami, P. R. et al. (2021) ‘Pemeriksaan GeneXpert Terhadap Tingkat Positivitas Pemeriksaan Basil Tahan Asam (BTA) Metode Ziehl Neelsen Pada Penderita Suspek TB Paru’, Jurnal Kesehatan Perintis (Perintis’s Health Journal), 8(1), pp. 82–90. doi: 10.33653/jkp.v8i1.598.
WHO (2021) Global Tuberculosis Report 2021. 2021st edn. Jenewa: WHO.